Acurx Pharmaceuticals, Inc. Stock Issued During Period, Shares, Conversion of Units
Acurx Pharmaceuticals, Inc. (ACXP) had Stock Issued During Period, Shares, Conversion of Units of 7.04 million shares as of 2021-06-29, per its 10-Q filed 2023-11-13.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits · last filed 2023-11-13
- 2021-06-29: Stock Issued During Period, Shares, Conversion of Units 7.04M shares.
- 2021-06-23: Stock Issued During Period, Shares, Conversion of Units 7.04M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units |
|---|---|
| 2021-06-29 | 7.04M shares 10-Q · filed 2023-11-13 |
| 2021-06-23 | 7.04M shares 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |